UBS AM’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.8M Buy
416,253
+107,357
+35% +$3.55M ﹤0.01% 1197
2025
Q1
$12.4M Sell
308,896
-6,354
-2% -$255K ﹤0.01% 1139
2024
Q4
$14.8M Buy
315,250
+48,494
+18% +$2.28M ﹤0.01% 1075
2024
Q3
$14.1M Buy
266,756
+14,814
+6% +$782K ﹤0.01% 1087
2024
Q2
$13.7M Buy
251,942
+134,020
+114% +$7.26M ﹤0.01% 1009
2024
Q1
$8.27M Buy
117,922
+1,357
+1% +$95.1K ﹤0.01% 1064
2023
Q4
$9.73M Sell
116,565
-4,279
-4% -$357K ﹤0.01% 993
2023
Q3
$3.56M Buy
120,844
+5,298
+5% +$156K ﹤0.01% 1364
2023
Q2
$4.07M Hold
115,546
﹤0.01% 1332
2023
Q1
$4.07M Buy
115,546
+18,254
+19% +$642K ﹤0.01% 1332
2022
Q4
$4.46M Buy
97,292
+15,513
+19% +$711K ﹤0.01% 1207
2022
Q3
$3.96M Sell
81,779
-17,671
-18% -$856K ﹤0.01% 1281
2022
Q2
$3.91M Buy
99,450
+5,807
+6% +$228K ﹤0.01% 1306
2022
Q1
$3.45M Sell
93,643
-525
-0.6% -$19.3K ﹤0.01% 1516
2021
Q4
$4.29M Buy
94,168
+24,758
+36% +$1.13M ﹤0.01% 1490
2021
Q3
$2.48M Buy
69,410
+6,475
+10% +$231K ﹤0.01% 1736
2021
Q2
$1.25M Sell
62,935
-482
-0.8% -$9.54K ﹤0.01% 2092
2021
Q1
$1.48M Buy
63,417
+9,842
+18% +$229K ﹤0.01% 1894
2020
Q4
$1.11M Buy
53,575
+647
+1% +$13.4K ﹤0.01% 1937
2020
Q3
$1.15M Buy
52,928
+4,519
+9% +$97.8K ﹤0.01% 1784
2020
Q2
$1.14M Sell
48,409
-10,952
-18% -$258K ﹤0.01% 1739
2020
Q1
$700K Buy
59,361
+12,680
+27% +$149K ﹤0.01% 1831
2019
Q4
$495K Sell
46,681
-11,291
-19% -$120K ﹤0.01% 2239
2019
Q3
$660K Buy
57,972
+28,948
+100% +$329K ﹤0.01% 2153
2019
Q2
$327K Hold
29,024
﹤0.01% 2379
2019
Q1
$235K Buy
29,024
+2,824
+11% +$22.8K ﹤0.01% 2405
2018
Q4
$166K Hold
26,200
﹤0.01% 2444
2018
Q3
$258K Hold
26,200
﹤0.01% 2331
2018
Q2
$217K Buy
+26,200
New +$217K ﹤0.01% 2447